Forbes December 8, 2021
Bernard Marr

Steve Jobs once said that the biggest innovations in the 21st century would be at the intersection of biology and technology. It’s no coincidence that as we go into 2022, biotechnology is the focus of many of Jobs’ fellow 20th-century tech visionaries, including Bill Gates and Paul Allen. As with all areas of technology, the global pandemic has accelerated both the development and adoption of biotech, with the hope that it will lead to new solutions for major global challenges, including illness, food shortages, and damage to the environment.

Even though, as we approach the end of 2021, biotech may be making headlines for the wrong reasons, genetic engineering, genome sequencing, and DNA modification have been shown to have tremendous...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Trends
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
STAT+: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
STAT+: Profiting from ‘legal’ insider trading isn’t always easy
Regeneron expands in gene editing with Mammoth deal

Share This Article